Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
130,702,820
-
Number of holders
-
14
-
Total 13F shares, excl. options
-
4,238,270
-
Shares change
-
-2,832,423
-
Total reported value, excl. options
-
$12,814,000
-
Value change
-
-$8,129,564
-
Number of buys
-
10
-
Number of sells
-
7
-
Price
-
$3.01
Institutional Holders of Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) as of Q3 2016
As of 30 Sep 2016 Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) had 20 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 4,238,270 shares of stock of the company.
Largest 10 holders included NEA Management Company, LLC, Abingworth LLP, GOLDMAN SACHS GROUP INC, SG Americas Securities, LLC, Redmile Group, LLC, RENAISSANCE TECHNOLOGIES LLC, UBS Group AG, Creative Planning, KCG Holdings, Inc., and BOOTHBAY FUND MANAGEMENT, LLC.
This table shows 20 institutional shareholders of the security as of 30 Sep 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.